Form 4: Colgate-Palmolive Director Bilbrey Acquires Additional Shares

Director John P. Bilbrey acquired 228 shares of Colgate-Palmolive common stock at $93.18 per share on January 2, 2025, through a deferred compensation plan.

Summary

• On January 2, 2025, John P. Bilbrey, a director of Colgate-Palmolive, acquired 228 shares of common stock at a price of $93.18 per share.
• The acquisition was made through a stock unit account as part of the Deferred Compensation Plan for Non-Employee Directors.
• Following the transaction, Bilbrey directly owns 33,273 shares and indirectly owns 4,719 shares through a trust.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects a routine transaction under a deferred compensation plan. It's a positive signal that a director is increasing their stake, but it's not necessarily indicative of a major shift in the company's prospects.

Positives

• The director's participation in the Deferred Compensation Plan demonstrates confidence in the company's future.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's valuation and future prospects. Acquisitions, especially by directors, are often viewed positively.

Stakeholder Impact

• The acquisition of shares by a director could be viewed positively by shareholders.

Key Dates